These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 17218962)
1. Anti-fibrotic effects of tetrandrine on bile-duct ligated rats. Hsu YC; Chiu YT; Lee CY; Wu CF; Huang YT Can J Physiol Pharmacol; 2006 Oct; 84(10):967-76. PubMed ID: 17218962 [TBL] [Abstract][Full Text] [Related]
2. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis. Hsu YC; Chiu YT; Cheng CC; Wu CF; Lin YL; Huang YT J Gastroenterol Hepatol; 2007 Jan; 22(1):99-111. PubMed ID: 17201889 [TBL] [Abstract][Full Text] [Related]
3. Effects of armepavine against hepatic fibrosis induced by thioacetamide in rats. Weng TC; Shen CC; Chiu YT; Lin YL; Huang YT Phytother Res; 2012 Mar; 26(3):344-53. PubMed ID: 21717514 [TBL] [Abstract][Full Text] [Related]
4. Effect of tetrandrine on experimental hepatic fibrosis induced by bile duct ligation and scission in rats. Park PH; Nan JX; Park EJ; Kang HC; Kim JY; Ko G; Sohn DH Pharmacol Toxicol; 2000 Dec; 87(6):261-8. PubMed ID: 11140824 [TBL] [Abstract][Full Text] [Related]
5. Antifibrotic effects of a herbal combination regimen on hepatic fibrotic rats. Lin YL; Hsu YC; Chiu YT; Huang YT Phytother Res; 2008 Jan; 22(1):69-76. PubMed ID: 17724770 [TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats. Chen WY; Lin SY; Pan HC; Liao SL; Chuang YH; Yen YJ; Lin SY; Chen CJ J Nutr Biochem; 2012 Mar; 23(3):252-64. PubMed ID: 21497498 [TBL] [Abstract][Full Text] [Related]
7. Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats. Chong LW; Hsu YC; Chiu YT; Yang KC; Huang YT J Biomed Sci; 2006 May; 13(3):403-18. PubMed ID: 16604421 [TBL] [Abstract][Full Text] [Related]
8. Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats. Younis N; Shaheen MA; Abdallah MH Biomed Pharmacother; 2016 Jul; 81():93-103. PubMed ID: 27261582 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of armepavine against hepatic fibrosis in rats. Weng TC; Shen CC; Chiu YT; Lin YL; Kuo CD; Huang YT J Biomed Sci; 2009 Sep; 16(1):78. PubMed ID: 19723340 [TBL] [Abstract][Full Text] [Related]
10. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats. Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714 [TBL] [Abstract][Full Text] [Related]
11. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855 [TBL] [Abstract][Full Text] [Related]
12. Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations. Tannuri AC; Coelho MC; de Oliveira Gonçalves J; Santos MM; Ferraz da Silva LF; Bendit I; Tannuri U J Pediatr Surg; 2012 Mar; 47(3):513-22. PubMed ID: 22424347 [TBL] [Abstract][Full Text] [Related]
13. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells. Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887 [TBL] [Abstract][Full Text] [Related]
14. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats. Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198 [TBL] [Abstract][Full Text] [Related]
15. Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats. Lee TY; Chang HH; Chen JH; Hsueh ML; Kuo JJ J Ethnopharmacol; 2007 Jan; 109(2):318-24. PubMed ID: 16989967 [TBL] [Abstract][Full Text] [Related]
16. Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats. Aksu B; Umit H; Kanter M; Guzel A; Aktas C; Civelek S; Uzun H Acta Histochem; 2010 May; 112(3):259-69. PubMed ID: 19217652 [TBL] [Abstract][Full Text] [Related]
18. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells. Zhao XY; Zeng X; Li XM; Wang TL; Wang BE Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):963-8. PubMed ID: 19413596 [TBL] [Abstract][Full Text] [Related]
19. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation. Mayoral P; Criado M; Hidalgo F; Flores O; Arévalo MA; Eleno N; Sánchez-Rodríguez A; López-Novoa JM; Esteller A Clin Sci (Lond); 1999 Mar; 96(3):297-305. PubMed ID: 10029566 [TBL] [Abstract][Full Text] [Related]
20. Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats. Olteanu D; Nagy A; Dudea M; Filip A; Muresan A; Catoi C; Mircea PA; Clichici S J Physiol Pharmacol; 2012 Oct; 63(5):483-96. PubMed ID: 23211302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]